Scavenger Compounds for Sequencing-by-Synthesis Error Reduction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current DNA sequencing methods face challenges in achieving high accuracy and efficiency, particularly in terms of error rates and read lengths, as next-generation sequencing technologies struggle to maintain reliability and throughput.

Innovation Solution

The use of indole-3-propionic acid, L-carnitine, and O-acetyl-L-carnitine as scavengers in sequencing-by-synthesis workflows, including cleaving, imaging, and washing steps, to enhance sequencing performance by reducing error rates and increasing read lengths through improved radical scavenging and oxidative stress mitigation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If traditional sequencing methods are used, then sequencing can be performed with established protocols, but error rates remain high and read lengths are limited

Engineering Contradiction:
Improvesequencing accuracyVSAvoidread length
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent introduces scavenger compounds (indole-3-propionic acid, L-carnitine, O-acetyl-L-carnitine) as intermediary substances that mediate between the sequencing reagents and the DNA template. These scavengers neutralize harmful radicals generated during sequencing reactions, thereby protecting the DNA and improving both accuracy and read length without interfering with the core sequencing mechanism

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent converts the harmful effect of radicals (which cause sequencing errors and limit read lengths) into a beneficial process. By introducing scavengers that specifically target and neutralize these radicals, the harmful byproducts of the sequencing reaction are transformed into an opportunity to improve sequencing performance and extend readable sequence lengths

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

2Productivity

If sequencing reactions are extended to increase read lengths, then more sequence information can be obtained, but error rates increase due to accumulated radicals

Engineering Contradiction:
Improveread lengthVSAvoiderror rate
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent applies preliminary action by adding scavenger compounds to the sequencing reaction mixture before the sequencing process begins. These scavengers are pre-positioned to neutralize radicals as they form during extended sequencing reactions, enabling longer reads while maintaining low error rates throughout the extended reaction period

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent ensures continuity of useful action by maintaining a constant presence of scavenger compounds throughout the extended sequencing reaction. This continuous scavenging activity allows the sequencing reaction to proceed for longer periods without accumulation of harmful radicals, thereby extending read lengths while preserving sequencing accuracy

Inventive Principle:
Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach results in lower error rates, higher sequence outputs, and longer read lengths, improving the overall efficiency and reliability of DNA sequencing processes.

Implementation Method 1

The use of indole-3-propionic acid, L-carnitine, and O-acetyl-L-carnitine as scavengers in sequencing-by-synthesis workflows to enhance sequencing performance by reducing error rates and increasing read lengths through improved radical scavenging and oxidative stress mitigation

Methodology Applied
Scientific EffectRadical scavenging: Oxidation

Data Source

PatentUS10036011B2Scavenger compounds for improved sequencing-by-synthesis
Publication Date: 2018.07.31 ISOPLEXIS CORP
  • US10036011B2 patent drawing
  • US10036011B2 patent drawing
  • US10036011B2 patent drawing

AI summary

The present invention discloses methods of applications of indole-3-propionic acid, L-carnitine and O-acetyl-L-carnitine in one or more different reactive steps of a sequencing-by-synthesis workflow. The reactive steps employing these compounds include, but are not limited to, cleaving, imaging, incorporating bases and washing. The use of these new compounds provides improved sequencing performance including, but not limited to, lower error rates, higher sequence outputs and/or longer read lengths.